When Treating Hepatitis C, 12 Weeks May Be Better
If you have a medical condition, it’s only natural to want the shortest—and fastest—course of treatment. The sooner you can get back to “life as usual,” the better you’ll feel.
Hepatitis C is no exception. However, recent research suggests that shortening your course of treatment with this liver infection may increase your risk of relapse.
6-Week vs 12-Week Hepatitis C Treatments: The Research
On October 1, 2021, the Journal of Hepatology published a study involving 188 people who had recently acquired hepatitis C. (1) Approximately one-half of the subjects received a combination of sofosbuvir and velpatisvir (such as in the drug Epclusa) for a period of six weeks. The remaining subjects received the same type of treatment for twice as long, or a total of 12 weeks.
Of the 93 people in the group receiving six weeks of treatment, nine subjects relapsed once these treatments ended. This equates to slightly more than one in ten. Conversely, of the 95 people receiving 12 weeks of the intervention drug, only two relapsed post-treatment.
Based on these results, the study’s authors concluded that shortening hepatitis C treatments from 12 weeks to six weeks appears to make them less effective, especially in cases where the infection was recently acquired.
Improving Your Hepatitis C Treatment Results
The American Liver Foundation stresses that “adherence to hepatitis C therapy is an important predictor of successful treatment.” (2) This includes going to any required doctor’s appointments, completing necessary tests, and following through with a treatment regimen.
Talking to your doctor can help you decide the best course (and length) of treatment for you based on your particular circumstances and needs.
During this conversation, the Foundation suggests:
- writing out your questions in advance so you don’t forget them
- being honest about how you’re feeling
- and taking notes during the appointment so you can review them later.
Taking actions such as these can help make your appointment more informative and, thus, more beneficial to your Hepatitis C treatment success.
(1) Matthews, G., Bhagani, S., Van der Valk, M., et al. (2021, October 01). Sofosbuvir/velpatasvir for 12 vs. 6 weeks for the treatment of recently acquired Hepatitis C infection. Journal of Hepatology. doi:10.1016/j.jhep.2021.04.056
(2) American Liver Foundation. (n.d.). Treating Hepatitis C. Retrieved October 28, 2021, from https://liverfoundation.org/for-patients/about-the-liver/diseases-of-the-liver/hepatitis-c/treating-hepatitis-c/#what-you-need-to-know-while-on-treatment